Synovial fibroblast hyperplasia correlates with rheumatoid arthritis duration and activity and is partially reversed by anti-TNF therapy

Meeting abstracts - A single PDF containing all abstracts in this Supplement is available at http://www.biomedcentral.com/content/files/pdf/1479-5876-8-S1-full.pdf.EMPTYUrl: http://www.biomedcentral.com/content/pdf/1479-5876-8-S1-info.pdf Introduction Synovial fibroblasts (SF) hyperplasia has been p...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of translational medicine 2010-11, Vol.8 (S1), p.P30-P30, Article P30
Hauptverfasser: Izquierdo, E, Cañete, J D, Celis, R, Del Rey, M J, Usategui, A, Marsal, S, Sanmartí, R, Criado, G, Pablos, J L
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Meeting abstracts - A single PDF containing all abstracts in this Supplement is available at http://www.biomedcentral.com/content/files/pdf/1479-5876-8-S1-full.pdf.EMPTYUrl: http://www.biomedcentral.com/content/pdf/1479-5876-8-S1-info.pdf Introduction Synovial fibroblasts (SF) hyperplasia has been proposed to contribute to the pathogenesis of rheumatoid arthritis (RA). Mononuclear cells, vascular CD31-positive endothelial cells and smooth muscle cells were not labelled.
ISSN:1479-5876
1479-5876
DOI:10.1186/1479-5876-8-S1-P30